-
PLA, PHA, and bio-based plasticizers were selected into the key catalogues of Beijing
Time of Update: 2022-10-09
Plasticizer, P34HB, and polylactic acid 3D printing filament The Institute of Biodegradable Materials reported that on April 25, the Beijing Municipal Bureau of Economics and Information Technology issued a notice on the issuance of the "Beijing Key New Materials First Batch Application Demonstration Guidance Catalog (2021 Edition)".
-
New technology of NK cell engineering based on bioorthogonal sugar metabolism and nanotechnology
Time of Update: 2022-08-12
New technology of NK cell engineering based on bioorthogonal sugar metabolism and nanotechnology Introduction of PI and research group: Cai Lintao , researcher, doctoral supervisor, director of the Institute of Medicine, Shenzhen Institute of Advanced Medicine, Chinese Academy of Sciences, director of the Nano Center .
-
Samsung Bioepis has teamed up with Takeda Pharmaceuticals to develop a number of biotherapy products for clinical treatment
Time of Update: 2021-02-20
On August 21st Samsung Bioepis said it had reached a strategic partnership agreement with Japan's Takeda Pharmaceuticals to jointly invest in and develop a number of biotherapy products for clinically unsolved disease treatments.
-
New development of the research daily NASH test: Genfit terminated the test CymaBay shelving
Time of Update: 2020-08-02
Favipiravir treatment of mild, moderate new crown patients small stage 3 clinical main endpoint recently, Glenmark developed the antiviral drug favipiravir generic FabiFlu, in a Phase 3 clinical study showed accelerated COVID-19 mild to moderate symptoms of patients to restore healthy cycle.
-
Science: scientists have successfully used the chain reaction of nine enzymes to make the HIV drug islatravir
Time of Update: 2019-12-10
December 10, 2019 / Bio Valley bio on / - recently, in a research report published in the international journal Science, researchers from Merck and kedicos successfully used a nine enzyme chain reacti
